INS and Hypoglycemia: In the largest study (ABCD) Thong et al. 43 reported an 8.9% incidence of hypoglycaemia among patients who used exenatide BID in combination with insulin and OAMs compared with a 6.1% incidence among those using exenatide BID without insulin.